|ARRAY BIOPHARMA INC filed this Form 10-K on 08/11/2017|
NOTE 2 – MARKETABLE SECURITIES
Marketable securities consisted of the following as of June 30, 2017 and 2016 (in thousands):
The mutual fund securities shown in the above tables are securities held under the Array BioPharma Inc. Deferred Compensation Plan.
The fair value of marketable securities are determined using quoted market prices from daily exchange-traded markets based on the closing price as of the balance sheet date and are classified as Level 1, as described in Note 8 - Fair Value Measurements to our financial statements included elsewhere in this Annual Report on Form 10-K.
As of June 30, 2017, the amortized cost and estimated fair value of available-for-sale securities by contractual maturity were as follows (in thousands):